MRK vs ZBH
By Alex · Tickerpine
Merck & Co., Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZBH |
|---|---|---|
| Price | $128.66 | $93.10 |
| Market cap | $317.77B | $18.01B |
| P/E ratio | 36.2 | 24.1 |
| ROE | 18.94% | 6.07% |
| Profit margin | 13.59% | 9.05% |
| Revenue growth | 4.90% | 9.30% |
| Dividend yield | 2.64% | 1.03% |
| Beta | 0.22 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZBH in plain English
- MRK is the bigger company — about 17.6× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.1 vs 36.2).
- MRK earns a higher return on equity (19% vs 6%).
- ZBH is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.64% vs 1.03%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.